Switch to:

Arena Pharmaceuticals Price-to-Owner-Earnings

: 3.50 (As of Today)
View and export this data going back to 2000. Start your Free Trial

As of today (2019-10-16), Arena Pharmaceuticals's share price is $49.14. Arena Pharmaceuticals's Owner Earnings per Share (TTM) for the trailing twelve months (TTM) ended in was $14.05. It's Price to Owner Earnings (TTM) ratio for today is 3.50.


NAS:ARNA' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 3.07   Max: 330.66
Current: 3.51

3.07
330.66

During the past 13 years, the highest Price to Owner Earnings (TTM) ratio of Arena Pharmaceuticals was 330.66. The lowest was 3.07. And the median was 22.73.


NAS:ARNA's Price-to-Owner-Earnings is ranked higher than
90% of the 146 Companies
in the Biotechnology industry.

( Industry Median: 27.04 vs. NAS:ARNA: 3.51 )

As of today (2019-10-16), Arena Pharmaceuticals's share price is $49.14. Arena Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2019 was $11.51. Therefore, Arena Pharmaceuticals's P/E ratio for today is 4.27.

As of today (2019-10-16), Arena Pharmaceuticals's share price is $49.14. Arena Pharmaceuticals's EPS without NRI for the trailing twelve months (TTM) ended in was $11.51. Therefore, Arena Pharmaceuticals's PE Ratio without NRI ratio for today is 4.27.

During the past 13 years, Arena Pharmaceuticals's highest PE Ratio without NRI was 5.48. The lowest was 3.57. And the median was 4.44.


Arena Pharmaceuticals Price-to-Owner-Earnings Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Arena Pharmaceuticals Annual Data
Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Price-to-Owner-Earnings Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Arena Pharmaceuticals Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Price-to-Owner-Earnings Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 3.18 4.17

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Arena Pharmaceuticals Price-to-Owner-Earnings Distribution

* The bar in red indicates where Arena Pharmaceuticals's Price-to-Owner-Earnings falls into.



Arena Pharmaceuticals Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Arena Pharmaceuticals's Price to Owner Earnings (TTM) Ratio for today is calculated as

Price to Owner Earnings (TTM) Ratio=Share Price/Owner Earnings per Share (TTM) (TTM)
=49.14/14.05
=3.50

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Arena Pharmaceuticals  (NAS:ARNA) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please go to this page.


Arena Pharmaceuticals Price-to-Owner-Earnings Related Terms


Arena Pharmaceuticals Price-to-Owner-Earnings Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)